scholarly journals Angiogenesis, Lymphangiogenesis and Lymphovascular Invasion: Prognostic Impact for Bladder Cancer Patients

10.5772/26676 ◽  
2012 ◽  
Author(s):  
Julieta Afonso ◽  
Lcio Lara ◽  
Adhemar Longatto-Filho
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Lymphovascular Invasion ◽  
Prognostic Impact

The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer

2008 ◽  
Vol 15 (7) ◽  
pp. 607-611 ◽  
Author(s):  
Edwin Herrmann ◽  
Eva Stöter ◽  
Arndt van Ophoven ◽  
Stefan Bierer ◽  
Christian Bolenz ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Lymphovascular Invasion ◽  
Pelvic Lymph Node ◽  
Prognostic Impact ◽  
Node Metastasis ◽  
Pelvic Lymph Node Metastasis

scholarly journals Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Shinji Ohtake ◽  
Takashi Kawahara ◽  
Ryo Kasahara ◽  
Hiroki Ito ◽  
Kimito Osaka ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Progression Free Survival ◽  
Neutrophil To Lymphocyte Ratio ◽  
Prognostic Impact ◽  
Free Survival ◽  
Lymphocyte Ratio ◽  
Kaplan Meier ◽  
Advanced Bladder Cancer ◽  
Overall Mortality

Introduction and Objectives. Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a simple marker of the systemic inflammatory response in critical care patients. We previously assessed the utility of NLR as a biomarker to predict tumor recurrence and cancer death in bladder cancer patients who underwent radical cystectomy. In this study, we evaluated the prognostic impact of NLR in bladder cancer patients who received gemcitabine and nedaplatin (GN) chemotherapy.Methods. A total of 23 patients who received GN chemotherapy for advanced bladder cancer were enrolled in this study. The cut-off point of NLR according to the sensitivity and specificity levels was derived from the area under receiver operator characteristics (AUROC) curve plotted for disease progression or overall mortality.Results. The NLR cut-off point was determined as 4.14 for both tumor progression and overall mortality. Median progression-free survival (PFS)/overall survival (OS) in the higher NLR group (NLR ≥ 4.14) and lower NLR group (NLR < 4.14) were 194/468 days versus 73/237 days, respectively. Kaplan-Meier analysis showed that higher NLR significantly correlated with poorer PFS (p=0.011) and OS (p=0.045).Conclusions. NLR may serve as a new biomarker to predict responses to GN-based chemotherapy in advanced bladder cancer patients and/or their prognosis.

scholarly journals Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients

2021 ◽  
Vol 18 (7) ◽  
pp. 1721-1729
Author(s):  
Xiaofei Wang ◽  
Yinghao Cao ◽  
Miaomiao Ding ◽  
Junqi Liu ◽  
Xiaoxiao Zuo ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Lymphovascular Invasion ◽  
Prognostic Impact ◽  
Colorectal Cancer Patients

scholarly journals Prognostic Impact of Schlafen 11 in Bladder Cancer Patients Treated with Platinum‐based Chemotherapy

2021 ◽  
Author(s):  
Daiki Taniyama ◽  
Naoya Sakamoto ◽  
Tsuyoshi Takashima ◽  
Masahiko Takeda ◽  
Quoc Thang Pham ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Prognostic Impact ◽  
Platinum Based Chemotherapy ◽  
Schlafen 11

895: Proteomic Analysis of Sera from Bladder Cancer Patients with MALDI-TOF-MS

2007 ◽  
Vol 177 (4S) ◽  
pp. 297-297
Author(s):  
Kristina Schwamborn ◽  
Rene Krieg ◽  
Ruth Knüchel-Clarke ◽  
Joachim Grosse ◽  
Gerhard Jakse
Keyword(s):  
Bladder Cancer ◽  
Cancer Patients ◽  
Proteomic Analysis ◽  
Maldi Tof Ms ◽  
Maldi Tof ◽  
Tof Ms
Sign in / Sign up

Export Citation Format

Share Document